Trial intelligence / Profile preview

Dexmedetomidine for Maintenance and Recovery in Cranial Aneurysm Surgery

NCT03355534Completed

Start
Jan 2018
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in cerebral aneurysm (3 arms). Primary endpoint: Incidence of coughing at 30 minutes. Started Jan 2018; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

cerebral aneurysm

Beyond the preview

Go deeper on NCT03355534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03355534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call